Atomoxetine now available as oral solution

Further information
View Strattera Oral Solution drug record
Summary of Product Characteristics
Manufacturer: Lilly

Strattera Oral Solution is licensed for the treatment of children, adolescents and adults with ADHD.

The liquid can be prescribed from the age of 6 years. The amount of solution to be given in children is dependent on body weight. To facilitate dosing, the product is packaged with a 10ml oral syringe marked in 1ml increments.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases